DrugPatentWatch Database Preview

Bausch Company Profile

BAUSCH has one hundred and forty approved drugs.

There are sixty-two US patents protecting BAUSCH drugs.

There are four hundred and fifteen patent family members on BAUSCH drugs in fifty-four countries and one hundred and forty-four supplementary protection certificates in fifteen countries.

International Patents:	415
US Patents:	62
Tradenames:	122
Ingredients:	99
NDAs:	140
Patent Litigation for Bausch:	See patent lawsuits for Bausch

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	7,214,506	Start Trial				Start Trial
Bausch And Lomb	ALBUTEROL SULFATE	albuterol sulfate	SOLUTION;INHALATION	075050-001	Jun 18, 1998		DISCN	No	No		Start Trial				Start Trial
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-002	Feb 6, 2003	AB	RX	Yes	No	6,923,984	Start Trial	Y			Start Trial
Bausch	MINOCIN	minocycline hydrochloride	CAPSULE;ORAL	050649-003	Feb 12, 2001		DISCN	Yes	No		Start Trial				Start Trial
Bausch	ISORDIL	isosorbide dinitrate	TABLET;ORAL	012093-001	Jul 29, 1988	AB	RX	Yes	Yes		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-006	Feb 6, 2003	5,529,791	Start Trial
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-005	Feb 6, 2003	7,108,866	Start Trial
Bausch	VASOTEC	enalapril maleate	TABLET;ORAL	018998-003	Dec 24, 1985	4,374,829*PED	Start Trial
Bausch	VASOTEC	enalapril maleate	TABLET;ORAL	018998-002	Dec 24, 1985	4,374,829*PED	Start Trial
Bausch	ZELAPAR	selegiline hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021479-001	Jun 14, 2006	5,648,093	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	75 mg	➤ Subscribe	2011-06-06
➤ Subscribe	Gel	0.77%	➤ Subscribe	2006-05-10
➤ Subscribe	Extended-release Tablets	120 mg, 180 mg, 240 mg, 300 mg and 360 mg	➤ Subscribe	2005-08-30
➤ Subscribe	Ophthalmic Solution	0.5%	➤ Subscribe	2012-10-19
➤ Subscribe	Cream	5%	➤ Subscribe	2006-10-17
➤ Subscribe	Ophthalmic Solution	1.5%	➤ Subscribe	2013-09-09
➤ Subscribe	Cream	3.75%	➤ Subscribe	2012-08-08
➤ Subscribe	Rectal Gel	2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mL	➤ Subscribe	2004-03-23
➤ Subscribe	Rectal Gel	5 mg/mL, 2mL pre-filled syringe	➤ Subscribe	2008-12-23
➤ Subscribe	Gel	1.2%/3.75%	➤ Subscribe	2015-09-30
➤ Subscribe	Vaginal Gel	0.75%	➤ Subscribe	2004-09-02
➤ Subscribe	Topical Solution	10%	➤ Subscribe	2018-06-06
➤ Subscribe	Extended-release Tablets	420 mg	➤ Subscribe	2005-04-25
➤ Subscribe	Ophthalmic Solution	0.07%	➤ Subscribe	2013-07-26
➤ Subscribe	Lotion	0.1%	➤ Subscribe	2016-08-31
➤ Subscribe	Cream	2.5%	➤ Subscribe	2014-06-17
➤ Subscribe	Rectal Gel	5 mg/mL, 4mL pre-filled syringe	➤ Subscribe	2008-12-08
➤ Subscribe	Gel	1.2%/2.5%	➤ Subscribe	2012-12-20

Patent Number	Expiration Date
Start Trial	Start Trial

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	201290050	Start Trial
European Patent Office	2730310	Start Trial
Mexico	2011009758	Start Trial
Cyprus	1117417	Start Trial
European Patent Office	1395215	Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1499331	SPC/GB13/034	United Kingdom	Start Trial	PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
2673237	LUC00111	Luxembourg	Start Trial	PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326
0284288	12/1998	Austria	Start Trial	PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
1874117	2014/032	Ireland	Start Trial	PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121
2712622	LUC00015	Luxembourg	Start Trial	PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.